A cross-national comparison of 17 countries' insulin glargine drug labels.

about

A cross-national comparison of 17 countries' insulin glargine drug labels.

Item

http://www.wikidata.org/entity/Q42195355

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

A cross-national comparison of 17 countries' insulin glargine drug labels.

@en

A cross-national comparison of 17 countries' insulin glargine drug labels.

@nl

type

Item

label

A cross-national comparison of 17 countries' insulin glargine drug labels.

@en

A cross-national comparison of 17 countries' insulin glargine drug labels.

@nl

prefLabel

A cross-national comparison of 17 countries' insulin glargine drug labels.

@en

A cross-national comparison of 17 countries' insulin glargine drug labels.

@nl

P1476

A cross-national comparison of 17 countries' insulin glargine drug labels.

@en

P2093

Jennifer M Polinski

http://www.w3.org/2001/XMLSchema#string

John D Seeger

http://www.w3.org/2001/XMLSchema#string

John G Connolly

http://www.w3.org/2001/XMLSchema#string

Niteesh K Choudhry

http://www.w3.org/2001/XMLSchema#string

William H Shrank

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Emergency hospitalizations for adverse drug events in older Americans

Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study

Lost in transmission--FDA drug information that never reaches clinicians.

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Introduction to the new prescription drug labeling by the Food and Drug Administration.

Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.

A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.

P304

159-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3704

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aaron S Kesselheim

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25250724

http://www.w3.org/2001/XMLSchema#string